Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member., Inc. (AMZN), Facebook Inc (FB): Top New Buys of Billionaire Jim Simons’ RenTech

Page 1 of 2

Jim SimonsRenaissance Technologies is not just another hedge fund. The fund charges a fixed fee of 5% and a performance fee of between 36% and 44%. The abnormally high fees are a result of high transaction costs that Renaissance Technologies incurs owing to its unconventional investment strategy. Using computational trading models for high frequency trading, the firm exploits market inefficiencies. For example, one such strategy is to use these algorithms to detect and front-run large transactions. The high fees are also due to the firm’s exceptional results, which have led to a rise in such quantitative investing by other investors.


Renaissance Technologies has about $65 billion worth of assets under management. At the end of March, the market value of its equity portfolio increased to $46.96 billion from $41.42 billion a quarter earlier. Technology and finance were the highest contributing sectors to the fund’s portfolio, containing 18% and 16% of the market value of its holdings respectively. The fund is very well-diversified, with its top ten holdings representing only 9.88% of its portfolio’s value. We picked through the fund’s latest 13F filing to find its largest new positions, stocks its algorithms have identified as good short-term bets. We’ll look at those stocks:, Inc. (NASDAQ:AMZN), Facebook Inc (NASDAQ:FB), Union Pacific Corporation (NYSE:UNP), and Priceline Group Inc (NASDAQ:PCLN), in this article.

The newly initiated stake in, Inc. (NASDAQ:AMZN) amounts to 1.15 million shares valued at $428.98 million and was the fund’s fourth largest equity holding overall, representing 0.91% of its portfolio’s value. However, this is not the first time that the $199.18 billion e-commerce giant has made it into the fund’s portfolio. Renaissance has been walking in and out of, Inc. (NASDAQ:AMZN) since the first quarter of 2001. The stock has appreciated by nearly 40% year-to-date, as it appears Simons’ fund has timed its latest re-entry well. Amazon’s cloud infrastructure, AWS, which is also the leader in the industry, registered phenomenal growth in the first quarter. Revenues from the segment stood at $1.57 billion, an increase of 49% year-over-year. This also led to Bernstein hiking, Inc. (NASDAQ:AMZN)’s price target to $600 from $450, while reiterating its ‘Outperform’ rating. Paul Ruddock and Steve Heinz‘s Lansdowne Partners is the largest stockholder of the company according to our database.

Facebook Inc (NASDAQ:FB) made an entry in Renaissance’s portfolio with some 2.65 million shares valued at $217.60 million. The social media platform company is continuing to engage more and more people worldwide; comScore reported that Facebook’s user engagement for April in terms of mobile internet time climbed to 24%, from 22% in March. The figure looks even more towering when compared to the 5% combined engagement from all other networking services including Twitter, Snapchat, and even Facebook Inc (NASDAQ:FB)’s own platforms, WhatsApp and Instagram. JPMorgan is certain about the company’s bright prospects in 2015, naming Facebook as one of its top picks for the year. Stephen Mandel of Lone Pine Capital held about 13.50 million shares of Facebook Inc (NASDAQ:FB) in his fund’s portfolio, according to its latest filing.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!